NL-OMON24798
Completed
未知
Treatment of atrial fibrillation in patients with high sympathetic activity by pulmonary vein isolation, renal artery denervation or both; an international randomized, controlled trial
Isala klinieken, department of Cardiology, Zwolle0 sites145 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- <p>Atrial fibrillation, hypertension</p>
- Sponsor
- Isala klinieken, department of Cardiology, Zwolle
- Enrollment
- 145
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •The patient falls within the target group resistent hypertension or symphatic overdrive
- •Patient is an acceptable candidate for renal denervation treatment
Exclusion Criteria
- •Contraindication to chronic anticoagulation therapy or heparin
- •Previous left heart ablation procedure for AF
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Interventional Strategies in Treatment of Atrial Fibrillation: Percutaneous Closure of the Left Atrial Appendage Versus Catheter AblationAtrial FibrillationNCT01363895Deutsches Herzzentrum Muenchen120
Completed
Not Applicable
Treatment of atrial fibrillation in patients with high sympathetic activity by pulmonary vein isolation in combination with renal denervation or pulmonary vein isolation only; an international randomized, controlled trial.Hypertensie en signalen van sympathische overactiviteitAtrial fibrillationhypertension10007521NL-OMON47122Isala Klinieken100
Completed
Not Applicable
Management of Atrial fibriLLation INcluding tailoring of anticoagulation in patients from primary care - ALL-Iabnormal heart rhythma-fib10007521NL-OMON44028Isala Klinieken Zwolle1,000
Completed
Not Applicable
Integrated management of the heart rhythm disorder atrial fibrillation, including stroke prevention with blood thinners and care for comorbidities, by the practice nurse and general practitioner in primary careAtrial fibrillation, anticoagulation, comorbidity, integrated care, primary care. Atriumfibrilleren, antistolling, comorbiditeit, integrale zorg, eerste lijn.NL-OMON23738Sponsor (verrichter) is the Isala hospital, Zwolle, the Netherlands. Performer (uitvoerder) is the Julius Center for Health Sciences and Primary Care of the University Medical Center Utrecht, The Netherlands.1,000
Completed
Not Applicable
Management of Patients With Atrial Fibrillation Undergoing Coronary Artery StentingAtrial FibrillationOral AnticoagulationPercutaneous Coronary InterventionNCT00596570University of Turku996